Medical Devices: Page 38


  • Signs for Johnson & Johnson are seen on company offices in California.
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    J&J unveils Varipulse data at AF Symposium

    The results compare favorably to data from Boston Scientific and Medtronic, although analysts noted that J&J enrolled younger patients.

    By Feb. 6, 2024
  • A head shot of Livanova CEO Vladimir Makatsaria.
    Image attribution tooltip
    Permission granted by Livanova
    Image attribution tooltip

    Livanova names J&J veteran Vladimir Makatsaria as CEO

    Makatsaria spent almost 30 years at J&J, rising to the top of its global Ethicon surgery business.

    By Feb. 6, 2024
  • the FDA Headquarters Explore the Trendline
    Image attribution tooltip
    Sara Silbiger via Getty Images
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • Image attribution tooltip
    Courtesy of Philips
    Image attribution tooltip

    Philips consent decree ‘worst case scenario’ for respiratory business

    The company may have to demonstrate years of compliance before it can sell sleep and respiratory products in the U.S. again, experts said.

    By Feb. 6, 2024
  • Judges Or Auctioneer Gavel On The Dollar Cash Background
    Image attribution tooltip
    Avosb via Getty Images
    Image attribution tooltip

    Nanostring files for bankruptcy protection, explores possible sale

    The life science tools company said it is evaluating whether to sell all or part of its business after attracting interest from potential buyers.

    By Feb. 5, 2024
  • Close-up of a sign with office building and trees in background
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Hologic wins FDA clearance for AI-enabled cervical cancer screening system

    The product creates digital images of Pap test slides and uses an AI algorithm to identify cells for review.

    By Feb. 5, 2024
  • A doctor puts a pulse oximeter on a patient's finger
    Image attribution tooltip
    Wavebreakmedia via Getty Images
    Image attribution tooltip

    FDA panel recommends new standards for pulse oximeters amid bias concerns

    Studies have found that pulse oximeters overestimated oxygen saturation in people with dark skin pigmentation, resulting in delayed care.

    By Feb. 5, 2024
  • Cardinal Health expands recall of Monoject syringes amid compatibility problems

    The company said there have been no reports of patient deaths, but noted there is a risk of serious injury or death.

    By Feb. 5, 2024
  • A circular device with a metal mesh around it.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards receives FDA approval for first transcatheter tricuspid valve replacement treatment

    The Evoque valve will serve patients with few treatment options, wrote RBC analyst Shagun Singh.

    By Feb. 2, 2024
  • An anatomical heart is pictured in red in a transparent body.
    Image attribution tooltip
    magicmine via Getty Images
    Image attribution tooltip

    CVRx names Kevin Hykes as CEO

    Kevin Hykes joins the company as it looks to grow the market for its device to improve heart failure symptoms. 

    By Feb. 2, 2024
  • A woman being visited by a nurse in her home
    Image attribution tooltip
    adamkaz via Getty Images
    Image attribution tooltip

    Usability challenges for at-home devices top ECRI’s 2024 hazards list

    The safety watchdog also identified inadequate or onerous device cleaning instructions as the second biggest health technology hazard this year.

    By Feb. 2, 2024
  • the FDA Headquarters
    Image attribution tooltip
    Sara Silbiger via Getty Images
    Image attribution tooltip

    FDA publishes final rule to harmonize quality system requirements with global standard

    The agency extended the transition timeline from one to two years, pushing back the effective date to 2026.

    By Feb. 1, 2024
  • FDA Commissioner Robert Califf speaks during the COVID Federal Response Hearing on Capitol Hill on June 16, 2022.
    Image attribution tooltip
    Joe Raedle/Getty Images via Getty Images
    Image attribution tooltip

    Califf backs increased LDT oversight despite industry opposition

    At a Wednesday event, the FDA commissioner named the laboratory-developed test proposal as a top priority and addressed questions on AI.

    By Feb. 1, 2024
  • A Philips factory
    Image attribution tooltip
    Patrik Stollarz / Staff via Getty Images
    Image attribution tooltip

    FDA receives more reports of deaths linked to Philips’ recalled respiratory devices

    From the start of July to the end of September last year, the agency received more than 7,000 reports that contained 111 deaths.

    By Feb. 1, 2024
  • Boston Scientific's Farapulse pulsed field ablation device.
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip

    Boston Scientific nets Farapulse approval, pushes back US TAVR launch

    The device maker disclosed it will start the highly anticipated launch of the AFib ablation device, but approval for its aortic valve replacement implant will have to wait. 

    By Jan. 31, 2024
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020, in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA extends deadline for comments on role of digital health in diabetes detection

    The agency is seeking answers on how digital health technologies could be used in the detection of prediabetes and Type 2 diabetes.

    By Jan. 31, 2024
  • An empty hospital operating theater is prepared with lighting and equipment
    Image attribution tooltip
    JohnnyGreig via Getty Images
    Image attribution tooltip

    The top medtech trends in 2024

    Experts said M&A, orthopedic procedure backlogs and emerging cardiac markets were among the top trends to watch in the medical device industry this year.

    By MedTech Dive Staff • Jan. 31, 2024
  • A sign announces the company name at Agilent's headquarters building in Santa Clara, California.
    Image attribution tooltip
    Permission granted by Agilent
    Image attribution tooltip

    Agilent, Incyte to partner on companion diagnostics

    The collaboration comes after Agilent restructured and sold its liquid biopsy unit. 

    By Jan. 30, 2024
  • The Shockwave Intravascular Lithotripsy (IVL) System with a Shockwave C2 Coronary IVL Catheter for low-pressure balloon dilatation of severely calcified, stenotic coronary arteries prior to stenting.
    Image attribution tooltip
    Permission granted by ShockWave
    Image attribution tooltip

    Shockwave Medical names Renee Gaeta CFO

    Gaeta is filling the vacancy created by Dan Puckett, who retired from the position this week.

    By Jan. 30, 2024
  • Red human heart drawing on blue background
    Image attribution tooltip
    Jolygon via Getty Images
    Image attribution tooltip
    Deep Dive

    4 heart device trends shaping the medtech sector in 2024

    Medtronic, Boston Scientific and J&J are among the medtech companies advancing treatments in cardiac care for when medicines are not enough.

    By Jan. 30, 2024
  • Vicarious Surgical
    Image attribution tooltip
    Permission granted by Vicarious Surgical
    Image attribution tooltip

    Vicarious Surgical hires former Olympus leader as president

    The appointment comes less than three months after a downsizing at the surgical robot maker. 

    By Jan. 30, 2024
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    What to watch for as Stryker, Boston Scientific and BD post earnings this week

    The next round of results follows reports from J&J, Abbott and Intuitive, all of which signaled a solid end to 2023.

    By Jan. 29, 2024
  • Image attribution tooltip
    Patrik Stollarz / Staff via Getty Images
    Image attribution tooltip

    Philips stops selling sleep, respiratory devices in US due to FDA consent decree

    The order is now being finalized ahead of its submission to a U.S. court for approval.

    By Jan. 29, 2024
  • Close-up of a sign with office building and trees in background
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Absolutions receives FDA breakthrough designation for abdominal wall closure device

    The device is designed to reduce the risk of hernia by distributing suture tension over a large area of tissue.

    By Jan. 26, 2024
  • layoffs
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Globus lays off Nuvasive employees after merger

    More than 150 positions in California were cut in January, according to a state notice reviewed by MedTech Dive.

    By Jan. 26, 2024
  • A green leaf on top of a white Apple logo outside a glass building at night.
    Image attribution tooltip
    Sascha Steinbach via Getty Images
    Image attribution tooltip

    How Masimo forced Apple to redesign its smartwatches

    In a long-running patent dispute, Masimo has compelled the tech giant to remove the pulse oximetry function of certain Apple Watches.

    By Jan. 26, 2024